checkAd
AVROBIO Aktie
 

AVROBIO, Inc. (Nasdaq:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced Geoff MacKay, president and CEO of AVROBIO, will present at the JMP Securities Life Sciences …

Wertpapier:

AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted a non-statutory stock option for the purchase of up to an …

Wertpapier:

Nachrichten

ZeitTitel
13.05.21
06.05.21
05.05.21
04.05.21
04.05.21
03.05.21
27.04.21
06.04.21
18.03.21
05.03.21
01.03.21
25.02.21
08.02.21
05.02.21
01.02.21
Diskussionen

AVROBIO Forum

Die wichtigsten Links der Community
Forum-Suche

Diskussionen

Was halten Sie von den neusten Entwicklungen zu AVROBIO?